Hsp90 as a target molecule for selective therapy in FLT3 positive AML

被引：0
|
作者：
Al-Shaer, LM [1 ]
Rowntree, CJ [1 ]
Mills, KI [1 ]
Tonks, A [1 ]
Darley, RL [1 ]
Burnett, AK [1 ]
机构：
[1] UWCM, Dept Haematol, Cardiff, S Glam, Wales
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2004年 / 125卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
57
引用
收藏
页码：18 / 18
页数：1
相关论文
共 50 条
  • [21] FLT3 Inhibitors in AML
    Stone, R. M.
    ANNALS OF HEMATOLOGY, 2015, 94 : S101 - S102
  • [22] FLT3 Inhibitors in AML
    Stone, R. M.
    ANNALS OF HEMATOLOGY, 2015, 94 (SUPPL 1) : 101 - 102
  • [23] FLT3 Inhibitors in AML
    Perl, Alexander
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S1 - S2
  • [24] Hsp90: A Drug Target?
    Holzbeierlein, Jeffrey M.
    Windsperger, Andrew
    Vielhauer, George
    CURRENT ONCOLOGY REPORTS, 2010, 12 (02) : 95 - 101
  • [25] Hsp90: A Drug Target?
    Jeffrey M. Holzbeierlein
    Andrew Windsperger
    George Vielhauer
    Current Oncology Reports, 2010, 12 : 95 - 101
  • [26] Treatment with Hsp90 Inhibitor, 17-AAG Overcomes Resistance to Small Molecule FLT3-Inhibitors in FLT3/ITD-Positive Leukemia Cells Harboring N676K-Mutation
    Minami, Yosuke
    Nomura, Yuka
    Abe, Akihiro
    Tanizaki, Ryohei
    Kuwatsuka, Yachiyo
    Kiyoi, Hitoshi
    Naoe, Tomoki
    BLOOD, 2008, 112 (11) : 572 - 573
  • [27] FLT3 inhibition and mechanisms of drug resistance in mutant FLT3-positive AML
    Weisberg, Ellen
    Barrett, Rosemary
    Liu, Qingsong
    Stone, Richard
    Gray, Nathanael
    Griffin, James D.
    DRUG RESISTANCE UPDATES, 2009, 12 (03) : 81 - 89
  • [28] Selective apoptosis of tandemly duplicated FLT3-transformed leukemia cells by Hsp90 inhibitors
    Y Minami
    H Kiyoi
    Y Yamamoto
    K Yamamoto
    R Ueda
    H Saito
    T Naoe
    Leukemia, 2002, 16 : 1535 - 1540
  • [29] Selective apoptosis of tandemly duplicated FLT3-transformed leukemia cells by Hsp90 inhibitors
    Minami, Y
    Kiyoi, H
    Yamamoto, Y
    Ueda, R
    Saito, H
    Naoe, T
    LEUKEMIA, 2002, 16 (08) : 1535 - 1540
  • [30] Is there evidence for the use of FLT3 inhibitors as maintenance therapy in AML?
    Levis, Mark
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2021, 34 (01)
12345